Malignant
Showing 1 - 25 of >10,000
Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate
Not yet recruiting
- Pleural Effusion, Malignant
- pleural markers
- (no location specified)
Jan 20, 2023
Malignant Tumors Trial in Beijing (BBPA PET examination)
Recruiting
- Malignant Tumors
- BBPA PET examination
-
Beijing, Beijing, ChinaWenbin Ma
Aug 4, 2023
Malignant Pleural Effusion, Thoracic Cancer Trial in Assiut (VATS-Surgical pleurodesis, Tube Drainage)
Recruiting
- Malignant Pleural Effusion
- Thoracic Cancer
- VATS-Surgical pleurodesis
- Tube Drainage
-
Assiut, EgyptAssiut university heart hospital
May 22, 2023
Malignant Pleural Mesothelioma Trial (Proton beam therapy)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Proton beam therapy
- (no location specified)
Dec 14, 2022
Malignant Pleural Effusion Trial in Wuhan (JMKX000197)
Recruiting
- Malignant Pleural Effusion
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 25, 2023
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Advanced Malignant Solid Tumors Trial (Neoantigen mRNA Personalised Cancer vaccine)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen mRNA Personalised Cancer vaccine
- (no location specified)
Jul 16, 2023
Malignant Tumor Trial in Beijing (99mTc-CNDG SPECT/CT)
Recruiting
- Malignant Tumor
- 99mTc-CNDG SPECT/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 3, 2023
New Method to Differentiate Benign and Malignant Pulmonary
Not yet recruiting
- Pulmonary Nodules
- (no location specified)
Sep 21, 2023
Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)
Not yet recruiting
- Malignant Pleural Effusion
- Malignant Ascites
-
Pittsburgh, PennsylvaniaAllegheny Health Network Cancer Institute
Aug 30, 2023
Advanced Malignant Tumor Trial in Jinan (JS207)
Not yet recruiting
- Advanced Malignant Tumor
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023
Patients With Diagnosis of Malignant Hyperthermia
Withdrawn
- Malignant Hyperthermia
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 13, 2022
Advanced Malignant Tumors Trial (NBL-020 for Injection)
Not yet recruiting
- Advanced Malignant Tumors
- NBL-020 for Injection
- (no location specified)
May 18, 2023
Cryobiopsy of Peripheral Lymph Nodes Trial in Fort Sam Houston (Cryobiopsy, Core Needle Biopsy)
Not yet recruiting
- Cryobiopsy of Peripheral Lymph Nodes
- Cryobiopsy
- Core Needle Biopsy
-
Fort Sam Houston, TexasBrooke Army Medical Center
Nov 1, 2023
Biliary Tract Carcinoma, Biliary Obstruction Trial in Brno (Cryobiopsy catheter)
Recruiting
- Biliary Tract Carcinoma
- Biliary Obstruction
- Cryobiopsy catheter
-
Brno, CzechiaBrno University Hospital
Sep 19, 2023
Advanced Malignant Cancer Trial (SHR-2022 Injection)
Not yet recruiting
- Advanced Malignant Cancer
- SHR-2022 Injection
- (no location specified)
Nov 8, 2023
Integrin avß6-targeted PET in Malignant Tumors
Recruiting
- Malignant Neoplasm
- +2 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Apr 18, 2023
Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)
Enrolling by invitation
- Malignant Melanomas
- Recombinant Human Adenovirus Type 5 Injection
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023
Analysis of Metabonomics for Pleural Effusion
Completed
- Pleural Diseases
- Detection of pleural effusion
- (no location specified)
Jun 15, 2023
Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)
Not yet recruiting
- Advanced Malignant Solid Tumors
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
May 23, 2023
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023
Malignant Ascites Trial in Taichung (Nivolumab, Pembrolizumab)
Enrolling by invitation
- Malignant Ascites
-
Taichung, Please Select, TaiwanChina Medical University Hospital
Feb 16, 2023
Recurrent or Metastatic Solid Tumors Trial (Recombinant Anti-EpCAM-CD3 Antibody Injection)
Not yet recruiting
- Recurrent or Metastatic Solid Tumors
- Recombinant Anti-EpCAM-CD3 Antibody Injection
- (no location specified)
Oct 17, 2023
Malignant Tumors Trial (IMMH-010)
Enrolling by invitation
- Malignant Neoplasms
-
Guangzhou, ChinaGuangdong Provincial People's Hospital
Dec 30, 2022
Malignant Solid Tumor Trial (GEN1042, Pembrolizumab, Cisplatin)
Not yet recruiting
- Malignant Solid Tumor
- GEN1042
- +4 more
- (no location specified)
Sep 21, 2023